The Latest Cardiac and Vascular News
FRAMINGHAM, Mass. , Aug. 17, 2022 /PRNewswire/ — Boston Heart Diagnostics, part of the Eurofins network of companies, announces the launch of LipidSeq™, a revolutionary genetic test for cardiovascular disease. This saliva-based NGS test identifies the most common genetic causes of lipid and lipoprotein disorders. These disorders are associated with premature cardiovascular, pancreatic, […]
IRVINE, Calif., Aug. 17, 2022 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), today announced the company’s PASCAL Precision transcatheter valve repair system received CE Mark for the treatment of mitral and tricuspid regurgitation (MR and TR). “Delivering the PASCAL Precision system to clinicians in Europe marks another significant step in our partnership with physicians who treat […]
Now over 1 in 5 Thoracic Organ Transplants are preserved using Paragonix Advanced Organ Preservation and Tracking Technology CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. is announcing a major milestone of preserving over 2,000 donor organs, providing transplant centers Advanced Organ Preservation (AOPT) technology and a nationwide clinical support network. Each of […]
Certification recognizes full-team approach to cardiac care DANVILLE, Pa., Aug. 17, 2022 /PRNewswire/ — Geisinger Medical Center (GMC) is the country’s first hospital to receive The Joint Commission/American Heart Association (AHA) Comprehensive Heart Attack Center Certification. Already recognized by the organizations as a Mission Lifeline® Heart Attack Receiving Center for its ability to […]
Funding Will Accelerate Commercialization of the ECGenius™ System and Expand Development of Analytic Modules COPENHAGEN, Denmark, Aug. 17, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the company has secured $7.2 million in funding from existing investors. The financing […]
PRINCETON, N.J., Aug. 17, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that the Israeli Ministry of Health (MoH) has approved national reimbursement for CytoSorb® in certain cardiac surgery indications that […]
– Katrin Rupalla, Ph.D., appointed Chair of Ambrx’s Board of Directors – – Ambrx to conduct strategic pipeline review with focus on commercial opportunity and cash runway extension – – Dr. Tian will continue to be available to Ambrx in an advisory capacity – SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or […]
Consistent evidence supports benefits of complete revascularization on LVEF, heart failure symptoms DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (Nasdaq: ABMD) announces the results of the Restore EF study demonstrate Impella-supported high-risk percutaneous coronary intervention (PCI) leads to significant improvements in left ventricular ejection fraction (LVEF), angina symptoms and heart failure symptoms at follow-up. The study, […]
HOUSTON, Aug. 16, 2022 /PRNewswire/ — Millar, Inc., a medical device manufacturer and OEM solutions partner, is pleased to announce that they have received approval from the Therapeutic Goods Administration (TGA) in Australia for their Mikro-Cath™ Pressure Catheter. The Mikro-Cath™ is a single–use pressure catheter intended to be used for medical research and diagnostic purposes. The […]
MOUNTAIN VIEW, Calif., Aug. 16, 2022 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced its Series F Financing led by GE Healthcare. Also joining the round are NGK-NTK (through a CVC partnership with Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, […]
